Composition with pharmacological effect for vaporizing and method
OwnerStephen C. Perryinventor
Life of this patent
Estimating the term…
Abstract
A composition is provided that includes a cannabinoid capable of inducing a pharmacological effect, an ester, a condensation aerosol, and a carrier liquid solution of food grade materials. The cannabinoid may include a bio-active ingredient receivable by a cannabinoid receptor and/or an acetylcholine receptor. The pharmacological effect may be produced by reception of tetrahydrocannabinol, cannabidiol, or mixtures thereof. The composition may also include ethanol, flavoring agents, and aromatherapy agents. The composition is deliverable to a user via vaporization. A method is provided for creating a pharmacological effect using the composition.
Claims16
A method for creating a pharmacological effect to treat diseases, conditions, and symptoms of illness that are treatable using a composition comprising a cannabinoid, the method comprising the steps of:
- (a) vaporizing the composition, wherein the composition comprises:
- a bio-active ingredient comprising a cannabinoid that is capable of inducing the pharmacological effect, wherein the cannabinoid is selected from the group consisting of dodeca-2E,4E,8Z,10E/Z-tetraenoic-acid-isobutylamides, cannabichromene, cannabicyclol, cannabivarin, tetrahydrocannabivarin, cannabidivarin, cannabichromevarin, cannabigerovarin, and cannabigerol monomethyl ether, an ester, a condensation aerosol, and a carrier liquid solution of food grade materials;
- (b) absorbing the composition into a mucosa;
- and
- (c) receiving the bio-active ingredient of the composition by a cannabinoid receptor or an acetylcholine receptor.
A method for creating a pharmacological effect to treat diseases, conditions, and symptoms of illness that are treatable using a composition comprising a cannabinoid, the method comprising the steps of:
- (a) vaporizing the composition, wherein the composition comprises:
- a bio-active ingredient comprising a cannabinoid that is capable of inducing the pharmacological effect, wherein the cannabinoid comprises dodeca-2E,4E,8Z,10E/Z-tetraenoic-acid-isobutylamides, an ester, a condensation aerosol, and a carrier liquid solution of food grade materials;
- (b) absorbing the composition into a mucosa;
- and
- (c) receiving the bio-active ingredient of the composition by a cannabinoid receptor or an acetylcholine receptor.
Dependencies are inferred from the claim text.